Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Change in Accured Expenses (2016 - 2025)

Plus Therapeutics has reported Change in Accured Expenses over the past 16 years, most recently at $688000.0 for Q4 2025.

  • Quarterly Change in Accured Expenses fell 79.62% to $688000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.6 million through Dec 2025, down 219.52% year-over-year, with the annual reading at -$5.6 million for FY2025, 219.52% down from the prior year.
  • Change in Accured Expenses was $688000.0 for Q4 2025 at Plus Therapeutics, up from -$1.1 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $4.5 million in Q4 2022 and troughed at -$3.6 million in Q1 2023.
  • The 5-year median for Change in Accured Expenses is $50000.0 (2023), against an average of $82117.6.
  • Year-over-year, Change in Accured Expenses soared 779.17% in 2024 and then plummeted 5523.26% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$461000.0 in 2021, then surged by 1075.49% to $4.5 million in 2022, then crashed by 91.46% to $384000.0 in 2023, then surged by 779.17% to $3.4 million in 2024, then tumbled by 79.62% to $688000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Change in Accured Expenses are $688000.0 (Q4 2025), -$1.1 million (Q3 2025), and -$2.8 million (Q2 2025).